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The chlorinated insecticide DDT is a persis-
tent environmental pollutant that undergoes
long-range atmospheric transport and is bio-
magniﬁed in food chains. Although its bio-
logical degradation in the environment is
slow, DDT is biotransformed to numerous
lipophilic and persistent metabolites that are
found in human tissues and in wild mam-
mals, birds, and ﬁsh. These degradation prod-
ucts include the dechlorinated metabolites
DDD and DDE and the sulfur-containing
DDE metabolite 3-methylsulfonyl-DDE
(MeSO2-DDE). All metabolites have a capac-
ity to interact with the endocrine system and
have deleterious effects on humans and exper-
imental and/or wild animals (1).
o,p´-DDD and p,p´-DDD are known to
be tissue-selective toxicants following local
metabolic activation and irreversible protein
binding in the adrenal cortex in several
species, including human (2), dog (3), and
mink (4). By virtue of its tissue-selective toxi-
city, o,p´-DDD is currently used as an
adrenocorticolytic drug to treat adrenocortical
carcinoma and Cushing’s disease (5).
MeSO2-DDE, along with a number of
polychlorinated biphenyl (PCB)-derived
methyl sulfones (MeSO2-PCBs), was
originally identiﬁed in the blubber of Baltic
grey seals (6). These persistent chemicals
subsequently have been found in human
breast milk, blood, and adipose tissue, as well
as in adipose tissue of arctic polar bears (7–9).
Several of these aryl methyl sulfones are char-
acterized by their cell- and tissue-speciﬁc dis-
tribution patterns in the body. In the search
for target cells of chlorinated aryl methyl
sulfones it was found that  14C-labeled
MeSO2-DDE produces a high and specific
accumulation in the adrenal zona fasciculata
in mice (10). Unlike the MeSO2-PCBs (poly-
chlorinated biphenyls), which are irreversibly
associated with speciﬁc PCB-binding proteins
in their target cells (e.g., in nonciliated bron-
chiolar cells), MeSO2-DDE is irreversibly
bound in the adrenal zona fasciculata cells.
MeSO2-DDE has subsequently been shown
to be a highly potent toxicant that induces
mitochondrial degeneration and cellular
necrosis following a CYP11B1-catalyzed
metabolic activation in the adrenal cortex in
mice (11,12).
Introduced in the early 1980s (13),
precision-cut tissue-slice culture has attracted
interest as a test system with which to exam-
ine drug metabolism in vitro (14–17).
Recently the adrenal medulla has been
examined with this method (18,19). We
have not found any reports using precision-
cut adrenal slices for studies of the cortical
function. Some authors have used quartered
adrenals or hand-cut adrenal slices (20–24).
Our objective has been to develop and apply
a test system based on tissue-slice culture
that allows examination of MeSO2-DDE
and other metabolism-activated adrenocorti-
colytic agents in human and wild animal
tissues. We now report on the use of
precision-cut adrenal slices to examine
metabolism-activated irreversible MeSO2-
DDE–binding, ultrastructural changes, and
effects on glucocorticosteroid secretion in
mouse and rat tissue. The results show that
adrenal tissue-slice culture is a promising ex
vivo test system for future studies on adrenal
toxicants in human and wild animals.
Materials and Methods
Chemicals. 3-Methylsulfonyl-2,2´-bis(4-
chloro-[14C]-phenyl)-1,1´-dichloroethene
(MeSO2-[14C]DDE; 13.4 mCi/mmol), unla-
beled MeSO2-DDE, and 2-(2-chlorophenyl)-
2-(4-chloro-[14C]-phenyl)-1,1-dichlorethane
(o,p´-[14C]DDD; 11.2 mCi/mmol) were pre-
pared as previously described (25,26).
DL[4,5-3H]leucine (40 Ci/mmol) was pur-
chased from Amersham Life Science
(Amersham, England). The radiochemical
purity was > 99% for all compounds.
Tetracosactide (Synacthen Depot, 1 mg/mL)
was obtained from Ciba (V. Frölunda,
Sweden). Bovine serum albumin (BSA),
dimethylsulfoxide (DMSO), and agarose
(Type VII, low melting temperature) were
obtained from Sigma (St. Louis, MO, USA).
2-Hydroxyethyl-methacrylate Technovit
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The persistent adrenocorticolytic DDT metabolite 3-methylsulfonyl-DDE (MeSO2-DDE) was
originally identiﬁed in Baltic grey seals, a population suffering from adrenocortical hyperplasia. In
mice, MeSO2-DDE induces mitochondrial degeneration and cellular necrosis in the adrenal zona
fasciculata. In this study, we used precision-cut tissue slice culture to examine local CYP11B1-cat-
alyzed irreversible binding of MeSO2-DDE in the murine adrenal cortex. We also examined
effects on steroid hormone secretion, histology, and ultrastructure. As determined by microau-
toradiography, selective binding occurred in zona fasciculata of slices exposed to MeSO2-[14C]-
DDE. Quantification of binding by phosphorautoradiography revealed a 3-fold reduction of
binding in slices co-exposed to the CYP11B1 inhibitor metyrapone. As measured by HPLC, cor-
ticosterone and 11-deoxycorticosterone secretion to the medium increased linearly for at least 24
hr. Addition of the ACTH analog tetracosactide caused an 8-fold increase in corticosterone secre-
tion. Addition of metyrapone reduced corticosterone secretion 4-fold. Exposure of slices to
MeSO2-DDE (50 µM) reduced the rate of corticosterone secretion by 90% after 24 hr of incuba-
tion. As determined by electron microscopy, vacuolated mitochondria were present in zona fascic-
ulata of slices exposed to MeSO2-DDE (50 µM) for 24 hr. Our ﬁndings show that all effects of
MeSO2-DDE previously reported in vivo could be reproduced in adrenal slice culture ex vivo.
This test system allows analysis of zone-specific irreversible binding and effects on steroid hor-
mone secretion and target cell ultrastructure. We propose adrenal slice culture as a simple ex vivo
test system with which to examine the adrenocorticolytic activity of xenobiotics in human and
wild animal tissue. Key words: adrenal cortex, DDT, endocrine disrupters, irreversible binding, 3-
MeSO2-DDE, tissue-slice culture, toxicity. Environ Health Perspect 109:105–110 (2001).
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http://ehpnet1.niehs.nih.gov/docs/2001/109p105-110lindhe/abstract.html
RESEARCH
Articles7100 was obtained from Kulzer (Wehrheim,
Germany) and TAAB 812 resin from TAAB
(Aldermaston, Berks, England). Osmium
tetroxide came from Analytical Standards AB
(Mölnlycke, Sweden) and uranyl acetate and
lead citrate from Merck (Darmstadt,
Germany). All liquids and dyes were from
Merck except chloroform, from Prolabo
(Paris, France). Liquid ﬁlm NTB2 was pur-
chased from Kodak (Rochester, NY, USA).
Aquasafe 300 Plus was obtained from Zinsser
(Frankfurt, Germany).
Animals. Female C57Bl mice (18–20 g)
and Sprague Dawley rats (100–160 g) were
obtained from Charles River, Uppsala,
Sweden. The animals were kept on a 12 hr
light:12 hr dark regimen and given a standard
pellet diet (Lactamin R36; Stockholm,
Sweden) and tap water ad libitum.
Preparation and incubation of tissue
slices. Animals were killed with carbon
dioxide. The adrenals were rapidly excised
and kept in ice-cold phosphate-buffered saline
(PBS) until embedding in 3% agarose.
Particular care was taken to arrange the adren-
als with the craniocaudal axis perpendicular to
the sectioning plane. Precision-cut slices (200
µm) were prepared in a Krumdieck tissue
slicer (Alabama Research and Development,
Munford, AL, USA) in ice-cold PBS (13).
Slices of equal size cut through the central
part of the adrenal were placed on titanium
screen holders (two to four slices per holder).
The holders were transferred to standard six-
well plates containing fully supplemented
Dulbecco’s modified Eagle’s Medium
(FDMEM, 2.5 mL) supplemented with fetal
bovine serum (FBS, 2%), gentamycin (0.1%),
L-glutamine (2 mM), penicillin (100 U/mL),
streptomycin (100 µg/mL), and 2-mercap-
toethanol (50 µM; National Veterinary
Institute, Uppsala, Sweden). Slices were
placed in culture within 1 hr of excision. The
plates were kept rotating (1 rpm) on an
inclined plane in an incubator (95% air/5%
CO2 at 38°C), thus allowing the slices to
alternate between medium and incubator
atmosphere. Incubation time ranged from 3
to 60 hr.
To inhibit CYP-dependent enzyme activ-
ity in the slices, some incubation wells were
supplemented with the CYP11B1 (11β -
hydroxylase) inhibitor metyrapone (50 µM)
and preincubated for 30 min before renewing
the medium. The synthetic ACTH analog
tetracosactide was added (11 nM) to stimulate
ACTH-regulated enzyme activity in the slices.
The labeled and unlabeled test substances
(MeSO2-DDE and o,p´-DDD) were added to
the fresh incubation medium, dissolved in
DMSO (not exceeding 0.5% of total volume)
and also with metyrapone when applicable.
Protein synthesis. Slices (four slices per
well) were incubated in FDMEM (2.5 mL)
supplemented with 3H-leucine (0.4 µCi/mL)
for up to 96 hr. Slices and medium (1 mL)
were sampled every 12 hr. After sampling,
slices were washed in PBS and homogenized
in distilled water (1 mL). We determined pro-
tein content using a ﬂuorescence-based pro-
tein assay (27). Samples of homogenate (50
µL) were added in duplicate to a 96-well plate.
The wells were then supplemented with PBS
(85 µL, pH 7.8) and ﬂuorescamine (140 µL)
dissolved in acetonitrile 0.3 mg/mL) and kept
at room temperature for 15 min. Fluorescence
was then measured in a Fluostar microplate
reader (SLT Labinstruments GmbH, Grödig/
Salzburg, Austria) excitation at 390 nm and
emission at 460 nm. We calculated protein
content using a standard curve prepared with
BSA (0–250 µg/mL) (27).
Incorporation of 3H-leucine into protein
was measured in aliquots of the homogenate
(0.5 mL), to which 2 M potassium hydroxide
(KOH, 0.5 mL) was added. After mixing,
1.5 M acetic acid (1 mL) was added and the
samples were centrifuged (300g, 20 min).
The protein pellets were washed with 1.5 M
acetic acid and centrifuged twice as above,
before being dissolved in 0.5 M sodium
hydroxide (0.5 mL). The solution was neu-
tralized with 2 M hydrochloric acid (125 µL)
and an aliquot (500 µL) was dissolved in
scintillation liquid (Aquasafe 300 Plus; 5
mL). Radioactivity was measured in a Tri-
Carb 1900CA (Packard, Downers Grove, IL,
USA) liquid scintillator counter.
Hormone analysis. Corticosterone, 11-
deoxycorticosterone, and aldosterone concen-
trations in the medium were measured with
HPLC using UV detection (241 nm).
Medium (1 mL) was removed and steroid
hormones were extracted twice with chloro-
form:methanol (2:1, 1.5 mL). The combined
chloroform phases were evaporated to dry-
ness, redissolved in acetonitrile (50%), and
injected into the HPLC system (Lichrosorb
RP 18 column, 20 cm, 5 µm particle size;
Merck). The steroid products were separated
using a linear gradient of 40–80% acetoni-
trile (1 mL/min) and mixed with 40%
methanol over 25 min. The amounts of
steroids were expressed as nmol/slice. The
detection level of steroid hormones was 5
pmol/mL medium.
Autoradiography. Microautoradiography.
Slices were incubated with MeSO2-
[14C]DDE (7.5 µM, 0.1 µCi/mL) or o,p´-
[14C]DDD (6.3 µM, 0.1 µCi/mL) for 24 hr,
as above. The labeled substances were added
to the medium dissolved in DMSO to local-
ize enzyme-catalyzed irreversible metabolite
binding.
Following incubation, the slices were ﬁxed
overnight in buffered formaldehyde (4%).
The ﬁxed slices were dehydrated in an ethanol
series (70%, 95%, and 100%) and embedded
in methacrylate. Particular care was taken to
orient the slices with the sliced plane parallel
to the sectioning plane. In a two-step embed-
ding procedure, the sections were ﬁxed in the
correct position with a minimal volume of
methacrylate and then mounted on a plastic
holder with the remaining methacrylate. The
mounted slices were sectioned (2 µm) in a
rotating microtome (HM 360; Mikrom
Laborgeräte GmbH, Walldorf, Germany).
Slides carrying the sectioned slices were dipped
in NTB2 liquid emulsion (Kodak) diluted
with an equal volume of distilled water. To
enable localization of irreversible binding in
metyrapone-treated mouse slices and rat slices,
an exposure time of 60 weeks (4°C) was
required to show clearly the localization.
General exposure time was 6–10 weeks.
Autoradiograms were developed, stained with
toluidine blue, and examined in a Leica (DM
RXE) light microscope. Photographs were
taken with a digital camera (Leica, Wetzlar,
Germany) and processed in Adobe Photoshop
5.5 (Adobe,  San Jose, CA, USA). Selected
autoradiograms were mounted and printed on
a Fujix Pictrography 3000 (Fuji, Japan).
Phosphorautoradiography.  Semi-
quantification of tissue-bound radioactivity
was performed by apposing tissue sections to
imaging plates (BAS-IP MP 2040S; Fuji,
Japan) for 14 days, before subjecting them to
microautoradiography. The radioactivity in
the labeled areas of the adrenal sections was
recorded by reading the imaging plate in a
phosphoimager (BAS 1500; Fuji, Japan)
(28,29). For semiquantiﬁcation of the tissue-
bound radioactivity, we used a Macintosh-
based bioimaging analyzer program (MacBAS,
ver. 2.2; Fujiﬁlm, Fuji, Japan). 
To correlate radioactivity and metaboli-
cally active regions in the incubated slices, we
marked the labeled areas of the images selec-
tively at 1 pixel resolution (1 pixel = 100 µm).
Values obtained were expressed as phosphos-
timulated luminiscence (PSL) minus back-
ground (BG) per square millimeter of 2-µm
thick tissue sections [(PSL-BG)/mm2].
Histopathology and electron microscopy.
We added MeSO2-DDE (dissolved in
DMSO) to the wells in amounts correspond-
ing to a ﬁnal concentration in the medium of
50 µM. Following incubation, slices were
embedded in methacrylate and prepared for
light microscopy, as above. For reference pur-
poses, some adrenal slices were ﬁxed directly
after sectioning. For transmission electron
microscopy, slices were ﬁxed overnight in glu-
taraldehyde (2.5% in 0.067 M N-cacodylate
buffer). They were then treated with osmium
tetroxide (1%, 2 hr at 4°C) rinsed in PBS
buffer, dehydrated in ethanol as described
above, treated with acetone, and embedded in
TAAB 812 resin. After we selected areas to be
examined, we cut ultrathin sections (50 nm)
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on copper grids and counterstained with
uranyl acetate (4%, 30 min) and lead citrate
(0.1 M, 5 min), and then examined with a
Philips EM 420 transmission electron micro-
scope at 60 keV (Philips, Eindhaven, the
Netherlands). 
Statistical evaluation of data. All statisti-
cal analyses of hormone concentrations and
bound radioactivity were made with a one-
way analysis of variance (ANOVA) (using
Dunnet’s posttest) or linear regression test
with GraphPad Prism software version 3.0 for
Windows (GraphPad Software, San Diego,
CA, USA).
Results
Protein synthesis. Adrenal slices exposed to
tetracosactide maintained a constant rate of
3H-leucine incorporation into protein [counts
per minute (CPM) per milligram protein],
which remained linear for 60 hr (Figure 1A).
Steroid hormone secretion. The rate of
corticosterone secretion from nontreated
adrenal slices remained constant for 30 hr.
We could detect no secretion of 11-deoxycor-
ticosterone from these slices.
In slices exposed to tetracosactide, accu-
mulation of corticosterone and 11-deoxycorti-
costerone in the medium increased linearly for
about 48 hr. Incubation for more than 48 hr
reduced the rate of secretion of corticosterone
and 11-deoxycorticosterone (Figure 1B).
Tetracosactide exposure for 24 hr increased
corticosterone content in the medium 8-fold
(p < 0.05), compared with that in nontreated
slices (Figure 2). Aldosterone content
increased almost 4-fold (p < 0.01) under the
same conditions (Figure 2).
In slices exposed to the CYP11B1
inhibitor metyrapone, the rate of corticos-
terone secretion was reduced about 4-fold
during 30 hr of incubation, compared with
nontreated slices. Exposure of slices to both
metyrapone and tetracosactide for 24 hr pro-
duced no significant decrease in corti-
costerone secretion, compared with slices
exposed to tetracosactide only. 11-Deoxy-
corticosterone secretion from slices exposed
to both tetracosactide and metyrapone
showed a 6-fold increase (p < 0.01), while
aldosterone secretion was more than halved
(p < 0.01), compared with slices exposed to
tetracosactide only (Figure 2).
Slices exposed to both MeSO2-DDE (50
µM) and tetracosactide showed a reduction in
the rate of corticosterone secretion (90%) at
time points exceeding 6 hr of incubation,
compared with slices exposed to tetracosactide
where the rate of corticosterone secretion
remained constant for 30 hr of incubation
(Figure 3). The levels of 11-deoxycorticos-
terone after 30 hr of incubation were similar
for both treatments.
Autoradiography. As determined by light
microscopy, autoradiograms of adrenal slices
co-exposed to MeSO2-[14C]DDE and tetra-
cosactide were characterized by a marked
labeling of zona fasciculata (Figure 4 A,B).
Labeling of zona glomerulosa, zona reticularis,
and the adrenal medulla did not exceed that of
the background. The localization of MeSO2-
[14C]DDE in nontreated slices did not differ
from that in tetracosactide-exposed slices. The
images of tissue-bound radioactivity semi-
quantified with phosphorautoradiography
matched the images of the microautoradi-
ograms closely. Phosphorautoradiography
showed no signiﬁcant increase in amount of
tissue-bound MeSO2-[14C]DDE in slices
exposed to tetracosactide, compared with non-
exposed slices. The MeSO2-[14C]DDE-
derived labeling in zona fasciculata in slices
exposed to both tetracosactide and metyra-
pone was reduced about 3-fold (p < 0.01),
compared with slices exposed to tetracosactide
only (Figure 4 C,D). Localization of
CYP11B1 mRNA using in situ hybridization
produced autoradiograms that corresponded
well with that of MeSO2-[14C]DDE labeling
(unpublished data). Corticosterone secretion
from slices exposed to MeSO2-(14C)DDE
(<7.5 µM) was roughly identical to that from
nontreated slices after 24 hr of incubation.
Rat adrenal slices exposed to MeSO2-
[14C]DDE for 24 hr showed very weak label-
ing of zona fasciculata after 60 weeks of
exposure (Figure 4 E,F). The levels of radioac-
tivity in these slices were too low to be semi-
quantiﬁed by phosphorautoradiography using
14 days exposure.
In contrast, microautoradiograms of
mouse adrenal slices exposed to o,p´-
[14C]DDD showed a very weak but selective
labeling of zona fasciculata and zona reticu-
laris (data not shown). Labeling of zona
glomerulosa and the adrenal medulla did not
exceed the background level The radioactivity
in these sections remained too weak to be
semiquantiﬁed by phosphorautoradiography
using 14 days exposure.
Light microscopy. Except for a slight
swelling of zona fasciculata cells, no obvious
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Figure 1. Protein synthesis and steroid hormone secretion determined in cultured adrenal slices incu-
bated up to 60 hr in 5% CO2 at 38°C. Medium and slices were sampled every 12 hr (n = 5); connecting lines
with standard error of the mean are shown. (A) Protein synthesis was determined by constant exposure
of the slices to 3H-leucine (0.4 µCi/mL) in the medium. (B) Secretion of corticosterone and 11-deoxycorti-
costerone was measured in 1 mL of medium. 
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Figure 2. Steroid secretion from adrenal slices
cultured for 24 hr. ND, not detectable. The secre-
tion of 11-deoxycorticosterone, aldosterone, and
corticosterone to the medium was increased by
tetracosactide (11 nM) treatment (a, p < 0.05; aa,
p < 0.01, compared with nontreated slices). The
secretion of 11-deoxycorticosterone was
increased and aldosterone was decreased by
combined metyrapone (50 µM) and tetracosactide
(11 nM) treatment (b, p < 0.01, compared with
tetracosactide-treated slices). (n = 5, ± SE). 
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Incubation time (hr)histologic changes could be observed after 24
hr of culture of tetracosactide-exposed slices,
compared with noncultured slices fixed for
histology immediately after slicing (Figure 5
A-B). In slices exposed to MeSO2-DDE, the
nuclei in zona fasciculata cells appeared more
condensed (Figure 5C).
Electron microscopy. Ultrastructural
examination of slices ﬁxed immediately after
sectioning revealed numerous mitochondria
and smooth endoplasmatic reticulum (SER)
in zona glomerulosa and zona fasciculata
cells. In slices kept 24 hr in culture, we
observed a reduced amount of SER in both
zones. Notably, the mitochondrial mem-
branes were largely intact in zona glomeru-
losa and zona fasciculata. Slices incubated
with MeSO2-DDE (50 µM) for 24 hr
showed mitochondrial vacuolation in zona
fasciculata. Mitochondria in zona glomeru-
losa remained largely intact and similar to
those in nonexposed slices incubated for 24
hr (Figure 6 A–F).
Discussion
In the present study, we developed an ex vivo
test system based on precision-cut adrenal
slice culture to examine metabolism-depen-
dent binding, ultrastructural changes, and
effects on steroid synthesis in mouse adrenal
tissue exposed to MeSO2-DDE. The results
showed that most metabolic and toxic events
previously reported in vivo or in vitro can be
reproduced ex vivo. In addition, the rate of
steroid hormone synthesis in tetracosactide-
exposed and nonexposed slices was readily
recorded. The results suggest that adrenal tis-
sue slice culture will become a useful test sys-
tem for examination of metabolism-activated
adrenal toxicants in both human and wild
animal tissue.
The viability of cultured slices was
defined largely by the toxicity-related test
variables examined. As determined by a series
of control experiments, nonexposed slices
maintained functional activity for at least 48
hr. The lack of apparent histologic change in
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Figure 4. Speciﬁc tissue binding in MeSO2-[14C]DDE-exposed adrenal mouse (A–D) and rat (E–F) slices cul-
tured in medium supplemented with tetracosatide (11 nM). Abbreviations: M, adrenal medulla; ZF, zona fas-
ciculata; ZG, Zona glomerulosa; ZR, zona reticularis. MeSO2-[14C]DDE binding was confined to zona
fasciculata in mouse adrenal slices, demonstrated by bright-field (A) and corresponding dark-field (B)
images. MeSO2-[14C]DDE binding in mouse zona fasciculata was reduced after addition of the CYP11B1
inhibitor metyrapone (50 µM) (C,D). In rat adrenal slices MeSO2-[14C]DDE binding was very weak but dis-
tinct in zona fasciculata after exposure to tetracosactide (11nM) (E,F). Magniﬁcation x220; bar = 100 µm.
Figure 5. Histologic examination of a control section from an adrenal slice not placed in culture (A), a slice exposed to tetracosactide (11nM) (B), and a slice co-
exposed to MeSO2-DDE (50µM) plus tetracosactide (11 nM) for 24 hr (C). Abbreviations: M, adrenal medulla; ZF, zona fasciculata; ZG, Zona glomerulosa; ZR, zona
reticularis. A slight swelling of zona fasciculata cells could be observed after 24 hr, as compared with noncultured slices. In MeSO2-DDE-exposed slices, the cell
nuclei in zona fasciculata appeared more condensed. Hematoxylin-eosin–stained sections; magniﬁcation x220; bar = 100 µm.the nonexposed slices following 24 hr in cul-
ture also supports the good viability of slices.
Ultrastructural examination, however,
revealed reduced numbers of SER vesicles
after 24 hr in culture, showing that the meta-
bolic functions of the SER could be affected
at this time point. It is noteworthy that the
mitochondrial membrane structure was
largely intact, compared with that of tissue
ﬁxed immediately after slicing. This observa-
tion is particularly important because
MeSO2-DDE is activated by CYP11B1, an
enzyme residing in the mitochondrial inner
membrane of zona fasciculata cells.
Phosphorautoradiography proved a sensi-
tive and quick tool to quantify levels of irre-
versible binding in the adrenal cortex.
Combined with the exact localization of
binding obtained by microautoradiography,
phosphorautoradiography is an efﬁcient tech-
nique with which to measure irreversibly
bound adduct levels in restricted target cell
populations in the cultured slices. The digi-
tized autoradiograms representing sites of
irreversible MeSO2-[14C]DDE binding cor-
related well with the localization of irre-
versibly bound radioactivity in conventional
microautoradiograms. The irreversible
MeSO2-[14C]DDE binding was conﬁned to
zona fasciculata, while zona glomerulosa,
zona reticularis, and the adrenal medulla
were devoid of bound radioactivity (above
the background levels). These results are con-
sistent with findings reported previously in
mice dosed with MeSO2-[14C]DDE in vivo.
They also confirm that CYP11B1 enzyme
activity was maintained in the cultured slices.
The CYP11A1-catalyzed cholesterol side-
chain cleavage is the first and rate-limiting
step in corticosterone synthesis. CYP11B1
catalyzes the last step in this pathway but also,
as mentioned, the metabolic activation of
MeSO2-DDE in the adrenal zona fasciculata
(12,30,31). Since tetracosactide stimulates
both CYP11A1 and CYP11B1 activity
(22,24,32–35), this peptide would be
expected to increase both corticosterone syn-
thesis and irreversible MeSO2-[14C]DDE
binding in the slice culture. The observed 8-
fold induction of corticosterone secretion by
tetracosactide was therefore expected and sup-
ports the conclusion that the cultured slices
retained their functional stability throughout
the experiment. Unexpectedly, however, no
increased MeSO2-[14C]DDE binding in zona
fasciculata was recorded by phosphorautoradi-
ography. A possible explanation for this
discrepancy could be that the increased
concentration of 11-deoxycorticosterone
induced by tetracosactide produced increased
competition with MeSO2-[14C]DDE for the
induced activating enzyme (11).
The reduced corticosterone secretion in
MeSO2-DDE–exposed slices may result
from mitochondrial toxicity, but also from
inhibition of CYP11B1 enzyme activity, as
previously reported in adrenal Y1 cells
(31,36). As demonstrated by electron
microscopy, the mitochondrial membranes
of zona fasciculata cells (the site of CYP11B1
localization) were vacuolated in the MeSO2-
DDE treated slices. The mitochondria in
zona glomerulosa remained largely intact.
This ﬁnding observed after 24 hr in culture
and the delayed inhibition of corticosterone
secretion suggests that toxicity was responsi-
ble (Figures 3 and 6). The mitochondrial
changes observed were similar to those previ-
ously described in vivo, but the inhibition of
corticosterone synthesis was more pro-
nounced in the cultured slices. This differ-
ence may be explained by the pituitary
feedback loop, which in the intact animal
compensates for decreasing glucocorticoid
serum levels by increasing the release of
ACTH.
In vivo, the potent CYP11B1 inhibitor
metyrapone blocks both synthesis of
corticosterone from 11-deoxycorticosterone
(37), and irreversible binding of MeSO2-
[14C]DDE to adrenal homogenate and the
mitochondrial fraction (11). Metyrapone
treatment of slices would consequently be
expected to inhibit both 11-deoxycorticos-
terone hydroxylation to corticosterone and
metabolism of MeSO2-[14C]DDE to a reac-
tive intermediate that becomes irreversibly
bound in the zona fasciculata cells. In the
present study, metyrapone did indeed reduce
corticosterone synthesis about 4-fold and
reduce irreversible MeSO2-[14C]DDE bind-
ing in zona fasciculata to a similar degree. A
comparable inhibition of irreversible MeSO2-
[14C]DDE binding was observed following
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Figure 6. Ultrastructural examination of sections from adrenal slices. Abbreviations: m, mitochondria; n,
nucleus; s, smooth endoplasmatic reticulum. Numerous mitochondria and SER characterize cells in zona
glomerulosa (A) and zona fasciculata (B) in reference slices ﬁxed immediately after sectioning. In slices
kept 24 hr in culture (C,D), a reduced amount of SER is observed. Notably, the mitochondrial membranes
are largely intact in zona glomerulosa (C) and zona fasciculata (D). Slices exposed to MeSO2-DDE (50 µM)
for 24 hr show mitochondrial vacuolation in zona fasciculata (F). Mitochondria in zona glomerulosa (E)
remain largely intact and similar to those in slices incubated without MeSO2-DDE for 24 hr (C).
Magniﬁcation x27,000; bar = 0.5 µm.exposure of slices to both tetracosactide and
metyrapone. It is noteworthy, however, that
the rate of corticosterone synthesis was not
significantly reduced by metyrapone in
tetracosactide-exposed cultures, in contrast to
cultures where slices were exposed only to
metyrapone. Notably, the concentration of
the CYP11B1 substrate 11-deoxycorticos-
terone increased 6-fold in the co-exposed cul-
tures, supporting an inhibition of CYP11B1.
The failure to inhibit corticosterone synthesis
by metyrapone may consequently be due to
the increased substrate concentration for the
enzyme. The remaining catalytic activity of
CYP11B1 may sufﬁce to maintain unchanged
synthesis of corticosterone despite partial
(competitive) inhibition of the enzyme by
metyrapone. Moreover, metyrapone treat-
ment halved the secretion of aldosterone.
The application of tissue-slice culture
proved very useful for examining bioactiva-
tion and toxicity of MeSO2-DDE in the
mouse adrenal zona fasciculata ex vivo. To
evaluate further the reliability of this ex vivo
test system for studying metabolism-activated
adrenal toxicants, we performed experiments
with tissue from species known to be insensi-
tive to MeSO2-DDE and o,p´-DDD.
Microautoradiograms showed a very weak
binding of MeSO2-[14C]DDE to the rat zona
fasciculata. Similarly, we observed very weak,
but selective binding of o,p´-[14C]DDD in
zona fasciculata–reticularis in mouse adrenal
slices. These ﬁndings are consistent with the
low binding and toxicity of MeSO2-DDE in
rat and o,p´-DDD in mouse adrenal cortex in
vivo (38). The ﬁnding that o,p´-DDD, unlike
MeSO2-DDE, was irreversibly bound in zona
reticularis suggests that different CYP
enzymes are involved in the metabolic activa-
tion of these adrenal toxicants.
The Baltic grey seal population suffered
from adrenocortical hyperplasia and a suite of
other pathologic lesions (39,40). MeSO2-
DDE was found in blubber from these ani-
mals. The adrenocorticolytic activity of
MeSO2-DDE has been characterized in sub-
cellular adrenal fractions, cultured adrenal
cells, and intact experimental animals. As
shown by these studies, there are major differ-
ences in toxic potency between species, mice
being highly sensitive whereas rats appear
insensitive (4,11,36,38,41). Preliminary exper-
iments with precision-cut human adrenal
slices treated with MeSO2-[14C]-DDE and
o,p´-[14C]-DDD show consistent and promis-
ing results. Considering that MeSO2-DDE is
present in human milk and serum in high
concentrations (8,9), a risk evaluation of possi-
ble human toxicity is called for.
In conclusion, we have shown that the
bioactivation and mitochondrial toxicity of
MeSO2-DDE observed in vivo could be
reproduced ex vivo. We have also demon-
strated that steroid synthesis and secretion of
both mineralocorticoids and glucocorticoids
can be studied in adrenal slice cultures. We
propose adrenal tissue slice culture as a sim-
ple ex vivo test system with which to examine
the adrenocorticolytic activity of environ-
mental pollutants and drugs in human and
wild animal tissues.
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